arrow
J

Jane E. Visvader

walter and eliza hall institute of medical research
H指数:84
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Parity and lactation induce T cell mediated breast cancer protection

同源性和哺乳诱导T细胞介导的乳腺癌保护作用

Nature
IF48.5
2025-10-200
PRE
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma

全基因组活体内CRISPR筛选鉴定GATOR1复合物为Myc驱动的淋巴瘤的肿瘤抑制因子

2025-08-210
OAAI
MCL-1 safeguards activated hair follicle stem cells to enable adult hair regeneration

MCL-1保护活化的毛囊干细胞,以实现成年毛发再生

2025-03-221
OA
Ehf controls mammary alveolar lineage differentiation and is a putative suppressor of breast tumorigenesis
2024-08-010
OA
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers

鉴定异常管腔祖细胞和mTORC1作为BRCA2突变携带者的潜在乳腺癌预防靶标

2024-01-128
PRE
Three-dimensional genome architecture coordinates key regulators of lineage specification in mammary epithelial cells

三维基因组结构协调乳腺上皮细胞谱系规范的关键调控因子

2023-11-011
OAAI
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
2023-10-2422
OAAI
Gata-3 Negatively Regulates the Tumor-Initiating Capacity of Mammary Luminal Progenitor Cells and Targets the Putative Tumor Suppressor Caspase-14

Gata-3负调节乳腺腔祖细胞的肿瘤启动能力,并靶向假定的肿瘤抑制Caspase-14

2023-03-20116
OAAI
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells (Feb,10.1038/s41418-023-01122-3, 2023)
2023-02-240
OAAI
Generation of a CRISPR activationmouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance (vol 13, 4739, 2022)
2022-08-250
OAAI
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
2022-08-1214
OAAI